|Awarded On||November 02, 2011|
|Title||In-Situ PET Imaging for Adaptive Proton Therapy|
|Award Mechanism||Individual Investigator|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Yiping Shao|
|Cancer Sites||All Sites|
Proton therapy (PT) is a latest state-of-art radiation therapy that can focus high level radiations to a small target. In principle, this unique physical property will allow PT to become a targeted therapy for significantly improved therapy efficacy while simultaneously reduced dose to normal tissues and thus reduced treatment complications. However, PT could be more harmful than useful to a patient if the high dose were not delivered accurately. Currently, there is no noninvasive technology to monitor the distribution of radiation delivered inside a patient. This has forced clinicians take overly conservative treatment approaches in restricting doses to the tumor in order to ensure sparing ...